Sana Biotechnology (SANA) Retained Earnings (2020 - 2026)
Sana Biotechnology recorded quarterly Retained Earnings of -$2000.0 in Q1 2026, up 100.0% quarter-over-quarter from -$1.8 billion in Q4 2025, and up 100.0% year-over-year from -$1000.0 in Q1 2025.
Sana Biotechnology's Retained Earnings history runs 7 years deep, the most recent figure standing at -$2000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 100.0% year-over-year to -$2000.0; the TTM figure through Mar 2026 stood at -$2000.0 (up 100.0% YoY), while the FY2025 annual figure was -$1.8 billion, down 13207357.14% from the prior year.
- Retained Earnings came in at -$2000.0 for Q1 2026 at Sana Biotechnology, up from -$1.8 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $21000.0 in Q3 2025 to a low of -$1.8 billion in Q4 2025.
- A 5-year average of -$711.9 million and a median of -$490.4 million in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings soared 123.33% in 2024 and plunged 13207357.14% in 2025, its largest moves.
- Sana Biotechnology's Retained Earnings stood at -$4.3 million in 2022, then soared by 98.61% to -$60000.0 in 2023, then jumped by 123.33% to $14000.0 in 2024, then slumped by 13207357.14% to -$1.8 billion in 2025, then surged by 100.0% to -$2000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$2000.0, -$1.8 billion, and $21000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | -1.85 Bn |
| Sep 30, 2025 | 21,000.00 |
| Mar 31, 2025 | -1.65 Bn |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | -1.60 Bn |
| Jun 30, 2024 | -1.50 Bn |
| Mar 31, 2024 | -1.45 Bn |
| Dec 31, 2023 | -60,000.00 |
| Sep 30, 2023 | -1.25 Bn |
| Jun 30, 2023 | -865,000.00 |
| Mar 31, 2023 | -1.10 Bn |
| Dec 31, 2022 | -4.33 Mn |
| Sep 30, 2022 | -974.40 Mn |
| Jun 30, 2022 | -6.35 Mn |
| Mar 31, 2022 | -5.17 Mn |
| Dec 31, 2021 | -785.36 Mn |
| Sep 30, 2021 | -674.60 Mn |
| Jun 30, 2021 | -591.40 Mn |
| Mar 31, 2021 | 56,000.00 |
| Dec 31, 2020 | -429.43 Mn |